Skip to main content

M L71 (Letrozole 2.5 mg)

Pill with imprint M L71 is Pink, Round and has been identified as Letrozole 2.5 mg. It is supplied by Mylan Pharmaceuticals Inc.

Letrozole is used in the treatment of breast cancer, metastatic; breast cancer; breast cancer, adjuvant and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M L71

Letrozole

Imprint
M L71
Strength
2.5 mg
Color
Pink
Size
6.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Aromatase inhibitors, Hormones/antineoplastics
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-2071 (Discontinued)
Inactive Ingredients
silicon dioxide, D&C Red No. 27, FD&C Blue No. 2, FD&C Red No. 40, hypromelloses, lactose anhydrous, magnesium stearate, microcrystalline cellulose, polydextrose, polyethylene glycol, corn starch, sodium lauryl sulfate, sodium starch glycolate type A potato, titanium dioxide, triacetin

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "M L71"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.